09.04.2022 - PHILADELPHIA, April 08, 2022 (GLOBE NEWSWIRE) - AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in the United States and China focused on early cancer screening and . Seite 1
Investigation of the RNA N6-methyladenosine (m6A) modification in the progression of multiple tumours the tumour microenvironment in non-small cell lung cancer